The E-cadherin/catenin Complex: an Important Gatekeeper in Breast Cancer Tumorigenesis and Malignant Progression

Overview

Journal Breast Cancer Res

Specialty Oncology

Date 2001 Oct 13

PMID 11597316

Citations 156

Authors

G Berx

F VAN Roy

Affiliations

Soon will be listed here.

Abstract

E-cadherin is a cell-cell adhesion protein fulfilling a prominent role in epithelial differentiation. Data from model systems suggest that E-cadherin is a potent invasion/tumor suppressor of breast cancer. Consistent with this role in breast cancer progression, partial or complete loss of E-cadherin expression has been found to correlate with poor prognosis in breast cancer patients. The E-cadherin gene (CDH1) is located on human chromosome 16q22.1, a region frequently affected with loss of heterozygosity in sporadic breast cancer. Invasive lobular breast carcinomas, which are typically completely E-cadherin-negative, often show inactivating mutations in combination with loss of heterozygosity of the wild-type CDH1 allele. Mutations were found at early noninvasive stages, thus associating E-cadherin mutations with loss of cell growth control and defining CDH1 as the tumor suppressor for the lobular breast cancer subtype. Ductal breast cancers in general show heterogeneous loss of E-cadherin expression, associated with epigenetic transcriptional downregulation. It is proposed that the microenvironment at the invasive front is transiently downregulating E-cadherin transcription. This can be associated with induction of nonepithelial cadherins.

Citing Articles

A foundation model for clinical-grade computational pathology and rare cancers detection.

Vorontsov E, Bozkurt A, Casson A, Shaikovski G, Zelechowski M, Severson K Nat Med. 2024; 30(10):2924-2935.

PMID: 39039250 PMC: 11485232. DOI: 10.1038/s41591-024-03141-0.

Spatial heterogeneity in tumor adhesion qualifies collective cell invasion.

Prasanna C, Jolly M, Bhat R Biophys J. 2024; 123(12):1635-1647.

PMID: 38725244 PMC: 11214055. DOI: 10.1016/j.bpj.2024.05.005.

Multiplex, Quantitative, High-Resolution Imaging of Protein:Protein Complexes via Hybridization Chain Reaction.

Schulte S, Shin B, Rothenberg E, Pierce N ACS Chem Biol. 2024; 19(2):280-288.

PMID: 38232374 PMC: 10877569. DOI: 10.1021/acschembio.3c00431.

Prognostic Value of Tumor Budding for Early Breast Cancer.

Silva D, Miranda G, Amaro T, Salgado M, Mesquita A Biomedicines. 2023; 11(11).

PMID: 38001907 PMC: 10669365. DOI: 10.3390/biomedicines11112906.

Reversible photoregulation of cell-cell adhesions with opto-E-cadherin.

Nzigou Mombo B, Bijonowski B, Raab C, Niland S, Brockhaus K, Muller M Nat Commun. 2023; 14(1):6292.

PMID: 37813868 PMC: 10562482. DOI: 10.1038/s41467-023-41932-0.

References

Graff J, Gabrielson E, Fujii H, Baylin S, Herman J . Methylation patterns of the E-cadherin 5' CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression. J Biol Chem. 2000; 275(4):2727-32. DOI: 10.1074/jbc.275.4.2727. View

Behrens J . Cadherins and catenins: role in signal transduction and tumor progression. Cancer Metastasis Rev. 1999; 18(1):15-30. DOI: 10.1023/a:1006200102166. View

Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, Baulida J . The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol. 2000; 2(2):84-9. DOI: 10.1038/35000034. View

Heimann R, Lan F, McBride R, Hellman S . Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin. Cancer Res. 2000; 60(2):298-304. View

Rahman N, STONE J, Coleman G, Gusterson B, Seal S, Marossy A . Lobular carcinoma in situ of the breast is not caused by constitutional mutations in the E-cadherin gene. Br J Cancer. 2000; 82(3):568-70. PMC: 2363330. DOI: 10.1054/bjoc.1999.0965. View

Nass S, Herman J, Gabrielson E, Iversen P, Parl F, Davidson N . Aberrant methylation of the estrogen receptor and E-cadherin 5' CpG islands increases with malignant progression in human breast cancer. Cancer Res. 2000; 60(16):4346-8. View

Grady W, Willis J, Guilford P, Dunbier A, Toro T, Lynch H . Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet. 2000; 26(1):16-7. DOI: 10.1038/79120. View

van de Wetering M, Barker N, Harkes I, van der Heyden M, Dijk N, Hollestelle A . Mutant E-cadherin breast cancer cells do not display constitutive Wnt signaling. Cancer Res. 2001; 61(1):278-84. View

Somasiri A, Howarth A, Goswami D, Dedhar S, Roskelley C . Overexpression of the integrin-linked kinase mesenchymally transforms mammary epithelial cells. J Cell Sci. 2001; 114(Pt 6):1125-36. DOI: 10.1242/jcs.114.6.1125. View

10.

Vasioukhin V, Bauer C, Degenstein L, Wise B, Fuchs E . Hyperproliferation and defects in epithelial polarity upon conditional ablation of alpha-catenin in skin. Cell. 2001; 104(4):605-17. DOI: 10.1016/s0092-8674(01)00246-x. View

11.

Tan C, Costello P, Sanghera J, Dominguez D, Baulida J, de Herreros A . Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells. Oncogene. 2001; 20(1):133-40. DOI: 10.1038/sj.onc.1204052. View

12.

Droufakou S, Deshmane V, Roylance R, Hanby A, Tomlinson I, Hart I . Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast. Int J Cancer. 2001; 92(3):404-8. DOI: 10.1002/ijc.1208. View

13.

Imbert A, Eelkema R, Jordan S, Feiner H, Cowin P . Delta N89 beta-catenin induces precocious development, differentiation, and neoplasia in mammary gland. J Cell Biol. 2001; 153(3):555-68. PMC: 2190562. DOI: 10.1083/jcb.153.3.555. View

14.

Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, Bruyneel E . The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell. 2001; 7(6):1267-78. DOI: 10.1016/s1097-2765(01)00260-x. View

15.

Rosen P, Lesser M, Senie R, Duthie K . Epidemiology of breast carcinoma IV: age and histologic tumor type. J Surg Oncol. 1982; 19(1):44-51. DOI: 10.1002/jso.2930190112. View

16.

Frixen U, Behrens J, Sachs M, Eberle G, Voss B, Warda A . E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol. 1991; 113(1):173-85. PMC: 2288921. DOI: 10.1083/jcb.113.1.173. View

17.

Mareel M, Behrens J, Birchmeier W, De Bruyne G, Vleminckx K, Hoogewijs A . Down-regulation of E-cadherin expression in Madin Darby canine kidney (MDCK) cells inside tumors of nude mice. Int J Cancer. 1991; 47(6):922-8. DOI: 10.1002/ijc.2910470623. View

18.

Vleminckx K, Vakaet Jr L, Mareel M, Fiers W, VAN Roy F . Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell. 1991; 66(1):107-19. DOI: 10.1016/0092-8674(91)90143-m. View

19.

Claus E, Risch N, Thompson W, Carter D . Relationship between breast histopathology and family history of breast cancer. Cancer. 1993; 71(1):147-53. DOI: 10.1002/1097-0142(19930101)71:1<147::aid-cncr2820710124>3.0.co;2-v. View

20.

Rasbridge S, Gillett C, Sampson S, Walsh F, Millis R . Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma. J Pathol. 1993; 169(2):245-50. DOI: 10.1002/path.1711690211. View